In addition to the Company's rapid organic growth and strong execution on strategic M&A, which to date includes 17 wholly owned subsidiary companies – MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland, H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia, HotHouse Consulting, MED Colombia, Agropro, Borela, ICC Labs, Whistler, and Chemi Pharmaceutical – Aurora is distinguished by its reputation as a partner and employer of choice in the global cannabis sector, having invested in and established strategic partnerships with a range of leading innovators, including: Radient Technologies Inc. RTI, Hempco Food and Fiber Inc. HEMP, Cann Group Ltd. CAN, Micron Waste Technologies Inc. MWM, Choom Holdings Inc. CHOO, CTT Pharmaceuticals CTTH, Alcanna Inc. CLIQ, High Tide Inc. HITI, EnWave Corporation ENW, Capcium Inc. (private), Evio Beauty Group (private), and Wagner Dimas (private).